Literature DB >> 33727605

Ocular phenotypes in a mouse model of impaired glucocerebrosidase activity.

Martin Weber1, Sang-Won Min2, Oded Foreman3, Abdoulaye Sene4, Baris Bingol5, Tom Truong4, Jeffrey Hung3, Stephanie Dale6, Mike Reichelt3, Savita Ubhayakar6, Carol Cain-Hom7, Miriam Baca3, Zhiyu Jiang2, Qingling Li8, Robert Brendza2, Han Lin2, Chung Kung7, William F Forrest9, Cristine Quiason-Huynh6, Wendy Sandoval8, Buyun Chen6, Yuzhong Deng6, Amy Easton2.   

Abstract

Mutations in the GBA1 gene encoding glucocerebrosidase (GCase) are linked to Gaucher (GD) and Parkinson's Disease (PD). Since some GD and PD patients develop ocular phenotypes, we determined whether ocular phenotypes might result from impaired GCase activity and the corresponding accumulation of glucosylceramide (GluCer) and glucosylsphingosine (GluSph) in the Gba1D409V/D409V knock-in (Gba KI/KI; "KI") mouse. Gba KI mice developed age-dependent pupil dilation deficits to an anti-muscarinic agent; histologically, the iris covered the anterior part of the lens with adhesions between the iris and the anterior surface of the lens (posterior synechia). This may prevent pupil dilation in general, beyond an un-responsiveness of the iris to anti-muscarinics. Gba KI mice displayed atrophy and pigment dispersion of the iris, and occlusion of the iridocorneal angle by pigment-laden cells, reminiscent of secondary open angle glaucoma. Gba KI mice showed progressive thinning of the retina consistent with retinal degeneration. GluSph levels were increased in the anterior and posterior segments of the eye, suggesting that accumulation of lipids in the eye may contribute to degeneration in this compartment. We conclude that the Gba KI model provides robust and reproducible eye phenotypes which may be used to test for efficacy and establish biomarkers for GBA1-related therapies.

Entities:  

Year:  2021        PMID: 33727605      PMCID: PMC7971029          DOI: 10.1038/s41598-021-85528-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  49 in total

Review 1.  MALDI imaging mass spectrometry: spatial molecular analysis to enable a new age of discovery.

Authors:  Megan M Gessel; Jeremy L Norris; Richard M Caprioli
Journal:  J Proteomics       Date:  2014-03-29       Impact factor: 4.044

2.  Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice.

Authors:  S W John; R S Smith; O V Savinova; N L Hawes; B Chang; D Turnbull; M Davisson; T H Roderick; J R Heckenlively
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-05       Impact factor: 4.799

3.  Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.

Authors:  Nick Dekker; Laura van Dussen; Carla E M Hollak; Herman Overkleeft; Saskia Scheij; Karen Ghauharali; Mariëlle J van Breemen; Maria J Ferraz; Johanna E M Groener; Mario Maas; Frits A Wijburg; Dave Speijer; Anna Tylki-Szymanska; Pramod K Mistry; Rolf G Boot; Johannes M Aerts
Journal:  Blood       Date:  2011-08-25       Impact factor: 22.113

4.  Glaucoma correlates with increased risk of Parkinson's disease in the elderly: a national-based cohort study in Taiwan.

Authors:  Shih-Wei Lai; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Curr Med Res Opin       Date:  2017-05-24       Impact factor: 2.580

5.  Retinal dystrophy associated with Danon disease and pathogenic mechanism through LAMP2-mutated retinal pigment epithelium.

Authors:  Masaya Fukushima; Tatsuya Inoue; Takashi Miyai; Ryo Obata
Journal:  Eur J Ophthalmol       Date:  2019-03-05       Impact factor: 2.597

6.  Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD.

Authors:  Michael E Ward; Alice Taubes; Robert Chen; Bruce L Miller; Chantelle F Sephton; Jeffrey M Gelfand; Sakura Minami; John Boscardin; Lauren Herl Martens; William W Seeley; Gang Yu; Joachim Herz; Anthony J Filiano; Andrew E Arrant; Erik D Roberson; Timothy W Kraft; Robert V Farese; Ari Green; Li Gan
Journal:  J Exp Med       Date:  2014-08-25       Impact factor: 14.307

7.  Ophthalmological features of Parkinson disease.

Authors:  Barbara Nowacka; Wojciech Lubinski; Krystyna Honczarenko; Andrzej Potemkowski; Krzysztof Safranow
Journal:  Med Sci Monit       Date:  2014-11-11

8.  Paediatric Fabry disease: prognostic significance of ocular changes for disease severity.

Authors:  Gisela Kalkum; Susanne Pitz; Nesrin Karabul; Michael Beck; Guillem Pintos-Morell; Rossella Parini; Marianne Rohrbach; Svetlana Bizjajeva; Uma Ramaswami
Journal:  BMC Ophthalmol       Date:  2016-11-16       Impact factor: 2.209

9.  Combination of acid β-glucosidase mutation and Saposin C deficiency in mice reveals Gba1 mutation dependent and tissue-specific disease phenotype.

Authors:  Benjamin Liou; Wujuan Zhang; Venette Fannin; Brian Quinn; Huimin Ran; Kui Xu; Kenneth D R Setchell; David Witte; Gregory A Grabowski; Ying Sun
Journal:  Sci Rep       Date:  2019-04-03       Impact factor: 4.379

10.  "Passenger gene" problem in transgenic C57BL/6 mice used in hearing research.

Authors:  Jun Suzuki; Hitoshi Inada; Chul Han; Mi-Jung Kim; Ryuichi Kimura; Yusuke Takata; Yohei Honkura; Yuji Owada; Tetsuaki Kawase; Yukio Katori; Shinichi Someya; Noriko Osumi
Journal:  Neurosci Res       Date:  2019-10-14       Impact factor: 3.304

View more
  2 in total

1.  Establishment and Phenotypic Analysis of the Novel Gaucher Disease Mouse Model With the Partially Humanized Gba1 Gene and F213I Mutation.

Authors:  Jia-Ni Guo; Ming Guan; Nan Jiang; Na Li; Ya-Jun Li; Jin Zhang; Duan Ma
Journal:  Front Genet       Date:  2022-05-27       Impact factor: 4.772

2.  PRINCESS: comprehensive detection of haplotype resolved SNVs, SVs, and methylation.

Authors:  Medhat Mahmoud; Harshavardhan Doddapaneni; Winston Timp; Fritz J Sedlazeck
Journal:  Genome Biol       Date:  2021-09-14       Impact factor: 13.583

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.